Berenberg Bank reaffirmed their buy rating on shares of CVS Group (LON:CVSG - Free Report) in a research note issued to investors on Tuesday morning, MarketBeat reports. They currently have a GBX 2,000 target price on the stock.
Separately, Royal Bank Of Canada reaffirmed an "outperform" rating and set a GBX 1,500 target price on shares of CVS Group in a research note on Friday, August 29th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, CVS Group presently has an average rating of "Buy" and an average target price of GBX 1,750.
View Our Latest Stock Analysis on CVSG
CVS Group Trading Up 0.8%
Shares of CVS Group stock traded up GBX 10 on Tuesday, reaching GBX 1,226. The company had a trading volume of 6,914,838 shares, compared to its average volume of 340,289. CVS Group has a 1 year low of GBX 791 and a 1 year high of GBX 1,342. The company has a debt-to-equity ratio of 110.52, a current ratio of 1.09 and a quick ratio of 0.90. The firm's 50-day moving average price is GBX 1,229.84 and its two-hundred day moving average price is GBX 1,159.71. The firm has a market cap of £879.53 million, a price-to-earnings ratio of 32,263.16, a P/E/G ratio of 1.77 and a beta of 1.02.
Insider Buying and Selling at CVS Group
In other news, insider Richard Fairman bought 1,644 shares of the stock in a transaction on Friday, July 11th. The stock was acquired at an average cost of GBX 1,216 per share, for a total transaction of £19,991.04. Corporate insiders own 1.38% of the company's stock.
About CVS Group
(
Get Free Report)
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Featured Stories
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
